Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Instil Bio Inc TIL

Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. The Company seeks to in-license/acquire and develop novel therapeutic candidates in diseases with significant unmet medical need. Its first such program is an engineered tumor infiltrating lymphocyte (TIL), cell therapy for the treatment of cancer. It is engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor (CoStAR), platform. The Company's lead CoStAR-TIL product candidate, ITIL-306, expresses a CoStAR molecule designed to recognize folate receptor alpha (Fra), a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC and renal cancer. CAR-T and TCR-T therapies are cell products composed of T cells that have been genetically engineered to recognize a specific cancer-related antigen on the surface of tumor cells.


NDAQ:TIL - Post by User

Bullboard Posts
Comment by thinker1951on Oct 26, 2010 11:22pm
329 Views
Post# 17616515

RE: RE: To the permabashers

RE: RE: To the permabashersCan you explain your share math a bit more. Not sure if I understand how he is up 30 grand and gets his shares back. Is it part of the pp terms??? Or are you assuming that he will be given new options??

I'm on the fence on this one. I thought the drill results were significant. Watched it run-up only to weaken quickly that disappointed me. Its like a no. of shareholders dumped at a convenient time. Perhaps they knew their was this pp coming. I certainly don't like evidence that an insider dumped 441,000 shares prior to this pp.

Most pp's seem to weaken the sp. Sometimes a little, sometimes a lot. Sometimes it bounces back quickly. I like this management teams aggressiveness they seem to be determined to find gold and lots of it. I hope I'm right. I see success here in the mid to long term. Imho right now because of the pp it may be a sideways or lower!
Bullboard Posts